Microinjection of different doses of corticotropin-releasing factor into the medial prefrontal cortex produces effects opposing anxiety-related behavior in rats

Journal of Nippon Medical School

Volumn 78, Issue 5, 2011, Pages 286-292

  Ohata, Hisayuki ^a   Shibasaki, Tamotsu ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Anxiety; Corticotropin releasing factor; Medial prefrontal cortex

Indexed keywords

CORTICOTROPIN RELEASING FACTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DOSE COMPARISON; FEAR; MALE; MAZE TEST; MICROINJECTION; NONHUMAN; PREFRONTAL CORTEX; RAT; TRANQUILIZING ACTIVITY; WISTAR RAT;

ANIMALS; ANTI-ANXIETY AGENTS; BEHAVIOR, ANIMAL; CORTICOTROPIN-RELEASING HORMONE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROINJECTIONS; PREFRONTAL CORTEX; RATS; RATS, WISTAR;

EID: 80054758219     PISSN: 13454676     EISSN: 13473409     Source Type: Journal    
DOI: 10.1272/jnms.78.286     Document Type: Article

References (39)

1. Dunn AJ, Berridge CW: Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses? Brain Res Rev 1990; 15: 71-100.
2. Chalmers DT, Lovenberg TW, De Souza EB: Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J Neurosci 1995; 15: 6340-6350.
3. Van Pett K, Viau V, Bittencourt JC, et al.: Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000; 428: 191-212.
4. Reul JM, Holsboer F: Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr Opin Pharmacol 2002; 2: 23-33.
5. Ohata H, Shibasaki T: The CRF peptide family in appetite regulation and energy balance. Curr Med Chem Cent Nerv Syst Agents 2003; 3: 243-255.
6. Joels M, Baram TZ: The neuro-symphony of stress. Nat Rev Neurosci 2009; 10: 459-466.
7. Ulrich-Lai YM, Herman JP: Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009; 10: 397-409.
8. Swanson LW, Sawchenko PE, Rivier J, Vale WW: Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983; 36: 165-186.
9. Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR: Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 1999; 92: 281-291.
10. Yan XX, Baram TZ, Gerth A, Schultz L, Ribak CE: Co-localization of corticotropin-releasing hormone with glutamate decarboxylase and calcium-binding proteins in infant rat neocortical interneurons. Exp Brain Res 1998; 123: 334-340.
11. De Souza EB, Insel TR, Perrin MH, Rivier J, Vale WW, Kuhar MJ: Corticotropin-releasing factor receptors are widely distributed within the rat central nervous system: an autoradiographic study. J Neurosci 1985; 5: 3189-3203.
12. Nemeroff CB, Owens MJ, Bissette G, Andorn AC, Stanley M: Reduced corticotropin releasing factor binding sites in the frontal cortex of suicide victims. Arch Gen Psychiatry 1988; 45: 577-579.
13. Kalin NH, Shelton SE, Davidson RJ: Cerebrospinal fluid corticotropin-releasing hormone levels are elevated in monkeys with patterns of brain activity associated with fearful temperament. Biol Psychiatry 2000; 47: 579-585.
14. Merali Z, Du L, Hrdina P, et al.: Dysregulation in the suicide brain: mRNA expression of corticotropin-releasing hormone receptors and GABAa receptor subunits in frontal cortical brain region. J Neurosci 2004; 24: 1478-1485.
15. Tan H, Zhong P, Yan Z: Corticotropin-releasing factor and acute stress prolongs serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons. J Neurosci 2004; 24: 5000-5008.
16. Jaferi A, Bhatnagar S: Corticotropin-releasing hormone receptors in the medial prefrontal cortex regulate hypothalamic-pituitary-adrenal activity and anxiety-related behavior regardless of prior stress experience. Brain Res 2007; 1186: 212-223.
17. Zieba B, Grzegorzewska M, Branski P, et al.: The behavioural and electrophysiological effects of CRF in rat frontal cortex. Neuropeptides 2008; 42: 513-523.
18. Paxinos G, Watson C: The rat brain in stereotaxic coordinates, 1997; Academic Press, San Diego.
19. Pellow S, Chopin P, File SE, Briley M: Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985; 14: 149-167.
20. Korte SM, De Boer SF, Bohus B: Fear-potentiation in the elevated plus-maze test depends on stressor controllability and fear conditioning. Stress 1999; 3: 27-40.
21. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT: CRF antagonist reverses the anxiogenic response to ethanol withdrawal in the rat. Psychopharmacology 1991; 103: 227-232.
22. Tezval H, Jahn O, Todorovic C, Sasse A, Eckart K, Spiess J: Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model. Proc Natl Acad Sci U S A 2004; 101: 9468-9473.
23. Prut L, Belzung C: The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003; 463: 3-33.
24. Sutton RE, Koob GF, Le Moal M, Rivier J, Vale W: Corticotropin releasing factor produces behavioural activation in rats. Nature 1982; 297: 331-333.
25. Samarghandian S, Ohata H, Yamauchi N, Shibasaki T: Corticotropin-releasing factor as well as opioid and dopamine are involved in tail-pinch-induced food intake of rats. Neuroscience 2003; 116: 519-524.
26. Kirby LG, Rice KC, Valentino RJ: Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus. Neuropsychopharmacology 2000; 22: 148-162.
27. Pernar L, Curtis AL, Vale WW, Rivier JE, Valentino RJ: Selective activation of corticotropin-releasing factor-2 receptors on neurochemically identified neurons in the rat dorsal raphe nucleus reveals dual actions. J Neurosci 2004; 24: 1305-1311.
28. Kirby LG, Freeman-Daniels E, Lemos JC, et al.: Corticotropin-releasing factor increases GABA synaptic activity and induces inward current in 5-hydroxytryptamine dorsal raphe neurons. J Neurosci 2008; 28: 12927-12937.
29. Gallopin T, Geoffroy H, Rossier J, Lambolez B: Cortical sources of CRF, NKB, and CCK and their effects on pyramidal cells in the neocortex. Cereb Cortex 2006; 16: 1440-1452.
30. Willins DL, Deutch AY, Roth BL: Serotonin 5-HT2a receptors are expressed on pyramidal cells and interneurons in the rat cortex. Synapse 1997; 27: 79-82.
31. Zhong P, Yan Z: Differential regulation of the excitability of prefrontal cortical fast-spiking interneurons and pyramidal neurons by serotonin and fluoxetine. PLoS One 2011; 6: e16970.
32. Nie Z, Schweitzer P, Roberts AJ, Madamba SG, Moore SD, Siggins GR: Ethanol augments GABAergic transmission in the central amygdala via CRF1 receptors. Science 2004; 303: 1512-1514.
33. Kash TL, Winder DG: Neuropeptide Y and corticotropin-releasing factor bi-directionally modulate inhibitory synaptic transmission in the bed nucleus of the stria terminalis. Neuropharmacology 2006; 51: 1013-1022.
34. Shah AA, Treit D: Infusions of midazolam into the medial prefrontal cortex produce anxiolytic effects in the elevated plus-maze and shock-probe burying tests. Brain Res 2004; 996: 31-40.
35. Shah AA, Sjovold T, Treit D: Inactivation of the medial prefrontal cortex with the GABAa receptor agonist muscimol increases open-arm activity in the elevated plus-maze and attenuates shock-probe burying in rats. Brain Res 2004; 1028: 112-115.
36. Amargos-Bosch M, Bortolozzi A, Puig MV, et al.: Co-expression and in vivo interaction of serotonin1a and serotonin2a receptors in pyramidal neurons of prefrontal cortex. Cereb Cortex 2004; 14: 281-299.
37. Magalhaes AC, Holmes KD, Dale LB, et al.: CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling. Nat Neurosci 2010; 13: 622-629.
38. Savitz J, Lucki I, Drevets WC: 5-HT1a receptor function in major depressive disorder. Prog Neurobiol 2009; 88: 17-31.
39. Orozco-Cabal L, Liu J, Pollandt S, Schmidt K, Shinnick-Gallagher P, Gallagher JP: Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration. J Neurosci 2008; 28: 529-542.